Harmony Biosciences Holdings, Inc. filed 3 current reports with the SEC under Item 5.02, which covers directors and officers leaving or being appointed, the latest on 2026-07-16. Between them they name 3 people, with 2 appointments and 1 departure. Each change below is quoted from the filing and linked to it.
Every change, newest first
Appointed: Stephen Mollichella, Principal Financial Officer, effective 2026-07-16
On July 16, 2026, the Board of Directors of the Company appointed Stephen Mollichella, the Company's Senior Vice President and Controller, as Interim Principal Financial Officer of the Company, effective as of July 16, 2026.
Appointed: Glenn Reicin, Chief Financial Officer, effective 2026-04-14
On April 14, 2026, the Company announced that Glenn Reicin has been appointed as Chief Financial Officer of the Company, effective as of April 14, 2026.
Departing: Antonio Gracias, Director
On March 31, 2026, Antonio Gracias, a Class III director of the Board, notified the Board that he would not stand for re-election as a director of the Company.
Find people with the same kind of experience as the Principal Financial Officer at Harmony Biosciences Holdings, Inc., with the record behind each one.
Find candidates like Principal Financial Officer at Harmony Biosciences Holdings, Inc.New leaders review vendors and budgets in their first months. Get an alert the next time Harmony Biosciences Holdings, Inc. is in the news or changes leadership.
Get an alert when Harmony Biosciences Holdings, Inc. changes leadershipTools for this story
Each opens in a new tab, filled in for Harmony Biosciences Holdings, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.